Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy

NCT05263830 · clinicaltrials.gov ↗

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

OTHER: Quantitative assay of GlypicanPC-3

Sponsor

Assistance Publique - Hôpitaux de Paris